EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antiviral Protein–Protein Interaction Inhibitors

Violeta Marković, Anna Szczepańska, Łukasz Berlicki iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.3c01543 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Violeta Marković und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wrocław University of Science and Technology, Department of Bioorganic Chemistry, Wyb. Wyspiańskiego 27, 50-370 Wrocław, Poland. Hauptthemen laut MEDLINE: Viruses, Chikungunya virus, Hemorrhagic Fever, Ebola. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 223 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Continually repeating outbreaks of pathogenic viruses necessitate the construction of effective antiviral strategies. Therefore, the development of new specific antiviral drugs in a well-established and efficient manner is crucial. Taking into account the strong ability of viruses to change, therapies with diversified molecular targets must be sought. In addition to the widely explored viral enzyme inhibitor approach, inhibition of protein-protein interactions is a very valuable strategy. In this Perspective, protein-protein interaction inhibitors targeting HIV, SARS-CoV-2, HCV, Ebola, Dengue, and Chikungunya viruses are reviewed and discussed. Antibodies, peptides/peptidomimetics, and small molecules constitute three classes of compounds that have been explored, and each of them has some advantages and disadvantages for drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VirusesChikungunya virusHemorrhagic Fever, EbolaHumansAntiviral AgentsEnzyme Inhibitors

Substanzen

Antiviral AgentsEnzyme Inhibitors

Autor:innen und Institutionen

  • Wrocław University of Science and Technology, Department of Bioorganic Chemistry, Wyb. Wyspiańskiego 27, 50-370 Wrocław, Poland.
  • University of Kragujevac, Faculty of Science, Department of Chemistry, R. Domanovića 12, 34000 Kragujevac, Serbia.

ORCID-Profile: Łukasz Berlicki

Förderung

  • Narodowe Centrum Nauki

Zitieren

APA

Marković, V., Szczepańska, A., & Berlicki, Ł. (2024). Antiviral Protein–Protein Interaction Inhibitors. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01543

Vancouver

Marković V, Szczepańska A, Berlicki Ł. Antiviral Protein–Protein Interaction Inhibitors. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.3c01543

BibTeX
@article{Markovi2024,
  author = {Marković, Violeta and Szczepańska, Anna and Berlicki, Łukasz},
  title = {Antiviral Protein–Protein Interaction Inhibitors},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.3c01543}
}
Kostenlos starten →